Identification of microRNA-regulated autophagic pathways in plant lectin-induced cancer cell death

Cell Prolif. 2012 Oct;45(5):477-85. doi: 10.1111/j.1365-2184.2012.00840.x. Epub 2012 Aug 8.

Abstract

Objectives: Plant lectins, carbohydrate-binding proteins of non-immune origin, have recently been reported to induce programmed cell death (including apoptosis and autophagy) in many types of cancer cells. MicroRNAs (miRNAs), small, non-coding endogenous RNAs, ~22 nucleotides (nt) in length, have been well characterized to play essential roles in regulation of the autophagy process in cancer; however, how these miRNAs regulate autophagic pathways in plant lectin-induced cancer cells, still remains an enigma.

Materials and methods: Identification of microRNA-regulated autophagic pathways was carried out using a series of elegant systems - biology and bioinformatics approaches, such as network construction, hub protein identification, targeted microRNA prediction, microarray analyses and molecular docking.

Results: We computationally constructed the human autophagic protein-protein interaction (PPI) network, and further modified this network into a plant lectin-induced network. Subsequently, we identified 9 autophagic hub proteins and 13 relevant oncogenic and tumour suppressive miRNAs, that could regulate these aforementioned targeted autophagic hub proteins, in human breast carcinoma MCF-7 cells. In addition, we confirmed that plant lectins could block the sugar-containing receptor EGFR-mediated survival pathways, involved in autophagic hub proteins and relevant miRNAs, thereby ultimately culminating in autophagic cell death.

Conclusions: These results demonstrate that network-based identification of microRNAs modulate autophagic pathways in plant lectin-treated cancer cells, which may shed new light on the discovery of plant lectins as potent autophagic inducers, for cancer drug discovery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy / drug effects
  • Autophagy / genetics*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology*
  • Cell Line, Tumor
  • Drug Discovery / methods
  • Female
  • Humans
  • MicroRNAs / genetics*
  • Oligonucleotide Array Sequence Analysis / methods
  • Plant Lectins / pharmacology*
  • Plant Lectins / therapeutic use
  • Protein Interaction Maps / drug effects
  • Protein Interaction Maps / genetics*
  • Signal Transduction / drug effects
  • Signal Transduction / genetics*

Substances

  • MicroRNAs
  • Plant Lectins